Oncology MRI

Clinical trial results show MRI as more accurate and less intrusive at diagnosis for men with a clinical suspicion of prostate cancer.

Men with intermediate-risk prostate cancer can be successfully treated with MRI-guided high-intensity focused ultrasound without experiencing incontinence or erectile dysfunction.

Prognosis for these patients is poor, but MRI can help providers reliably stage their disease.

Here's what to expect this week on Diagnostic Imaging.

Whole-body MRI was able to detect more lesions and identify more patients for earlier treatment.

Pairing MR-guided high intensity focused ultrasound with the standard-of-care, external beam radiotherapy, can offer faster pain relief to patients.

Using MRI-guided biopsy could help women avoid surgical resection to determine how well chemotherapy is working.

Here's what to expect this week on Diagnostic Imaging.

Using pre-operative MRI data, an AI algorithm can help predict recurrence better than existing models.

Suspicious lesions that develop during neoadjuvant therapy are uncommon, and they are highly unlikely to be malignant.

Pathological tumor size is frequently under-estimates the size of prostate tumors, particularly smaller tumors.

MRI reveals its wide utility this year, demonstrating improved performance in disease detection, as well as outperforming other modalities in providing clearer, more detailed images.

The tools incorporate a patient’s own clinical characteristics to identify which individuals with early-stage breast cancer will experience cancer spread and which will potentially have disease-free survival.

Here's what to expect this week on Diagnostic Imaging.

Research indicates patients who undergo a single 28-Gy session experience similar outcomes to those who have four 12-Gy sessions, pointing to safer, faster treatment.

3D technique manipulates radio waves and magnetic fields used for MRI to significantly increase tumor visualization on contrast-enhanced images.

18F-fluciclovine PET/MRI can improve treatment guidance with better staging and evaluation of androgen deprivation therapy.

Adding the 18F radiotracer to MRI scans provides more detail, leading to better treatment planning and better disease-free survival rates in men with recurrent prostate cancer.

Ultrasound as the New Stethoscope; Pre-Operative MRI and Dense Breasts; Spectral CT and COVID-19; Corporatization in Radiology

Algorithm cleared to help radiologists analyze and segment prostate MRI.

Results indicate radiologic findings are better survival predictors than pathologic vessel invasion.

Australian data reveals mpMRIp significantly decreases the need for prostate biopsies and controls healthcare spending.

PET/MRI vs. PET/CT; Abdominal CT and COVID-19; Chest MRI vs Chest CT; Expert Interpretations of Endometriosis; and Delayed Breast Cancer Treatments for African American Women

CEUS is a safer, less expensive option for diagnosing focal liver disease.

Treatment does not significantly change three-year disease-free survival rates.

States with expanded coverage saw an increase in cancer diagnosis for covered adults, as well as the overall population.

PET/MRI detects more lesions with less radiation, making it a great option for pediatric patients.

The company has captured 510(k) clearance for artificial intelligence-based software that facilitates brain and prostate image interpretations.

Relying on patient- or tumor-specific characteristic to recommend pre-operative MRI could result in missed cancers.

Diagnostic Imaging's Weekly Scan: July 3, 2020